UNSPSC 51152036: Mephenesin nicotinate

This classification denotes a muscle relaxant with the molecular formula C16H17NO4, a preparation that US FDA regulates as an active ingredient or moiety under Unique Ingredient Identifier 9490C46O95. Most nations schedule mephenesin nicotinate under HS 29094990 and SITC 51617. As of Q4 2014, MEPHENESIN NICOTINATE remains the US FDA Preferred Term for this commodity. SMILES: CC1=CC=CC=C1OCC(COC(=O)N)O.

UNSPSC 51152036 Mephenesin nicotinate is a Commodity code that does not align with the recent state and local solicitations tagged under it. The two recent opportunities on record — Seminole County, Florida's procurement of naloxone and drug deactivation systems, and the Texas Health and Human Services Commission's Request for Information on direct-to-manufacturer prescription programs — involve pharmaceutical supply, distribution, and pharmacy benefit management, not mephenesin nicotinate specifically. The source shows no concrete evidence that state and local governments are actively purchasing mephenesin nicotinate as a distinct product line under this code. The code's nominal definition refers to a specific pharmaceutical compound, but the solicitation records do not support active procurement activity in that category.

The two tagged opportunities reflect broader pharmaceutical and opioid-response procurement activity across state and local health agencies, but they represent misaligned code assignment rather than substantive market signals for the mephenesin nicotinate commodity itself. Without evidence of active solicitations specifically targeting this compound, the code shows little relevant recent activity from state and local buyers. Business development professionals evaluating this code should verify whether their product scope genuinely aligns with mephenesin nicotinate procurement or whether opportunities in related pharmaceutical commodities or health-system supplies fall under different UNSPSC classifications.